Clinical trial
Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine…
NCT00311493 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00311493 |
|---|---|
| Title | Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults |
| Official title | A Phase IV, Randomized, Open-Label, Multi-Center Study in Adults: Evaluation of Long-Term Immunogenicity in Subjects Boosted With a New TBE Vaccine for Adults (Free of Protein-Derived Stabilizer) in Study V48P2E1, 5 Years After First Booster Immunization and Evaluation of Booster Kinetics in… |
| Lead sponsor | Novartis, Industry |
| Collaborators | Novartis Vaccines Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Encephalitis, Tick-Borne |
| Intervention type | Biological |
| Interventions | Tick-Borne Encephalitis vaccine |
| Enrollment | 179 |
| Start date | Feb 1, 2006 |
| First posted | Apr 6, 2006 |
| Last update posted | Mar 13, 2007 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: